Steve Marlow

Steve began his career with CSL, in Australia in 2000. He was appointed to his current role, Senior Vice President (SVP) and General Manager of CSL’s Vaccine business unit, CSL Seqirus in April 2020 following five years leading CSL Seqirus’ Global Operations function from 2015 to 2020. Prior to this, Steve served as General Manager and SVP of CSL Behring’s US Manufacturing Operations, based in Illinois, USA. Further key leadership roles of note during Steve’s over 20-year career at CSL included responsibility for Supply Chain, International Commercial Operations and Technical Operations for the Influenza franchise. Steve led the global coordination for the rapid response to the H1N1 pandemic in 2009 and was at the forefront of CSL’s global response to the COVID-19 pandemic in 2020.

Steve gained his undergraduate degree in Leeds, UK, his MBA in Melbourne, Australia and is a graduate of the Advanced Management Program at the Melbourne Business School, Australia.